About

Caroline is driven to improve care for patients. Whether via basic cancer research, which she performed for her PhD studies at UMASS Medical school, USA in collaboration with Utrecht University, the Netherlands, clinical development of cell therapy at biotech Kiadis Pharma (currently Sanofi), assessment of drugs at the Dutch Health Care Institute, or reimbursement and market access, and communication activities at Pharma companies, optimizing care has always been the objective. After three years as European reimbursement director for genome expression test developer Agendia, she started Valence Consultancy to share her expertise more broadly.